Поиск

добавлена новая статья Другое

2026-05-12 17:04:42 -

Rising Prevalence of Breast Cancer Drives Growth in the HER2 Testing Market

As of May 2026, the Human Epidermal Growth Factor Receptor 2 (HER2) Testing Market is undergoing a pivotal expansion. No longer confined to a binary "positive" or "negative" result, the industry is transitioning toward precision subtyping, including the identification of "HER2-low" populations. This shift is driven by the regulatory approval of advanced antibody-drug conjugates (ADCs) like...

0 Комментарии 0 Поделились 203 Просмотры 0 предпросмотр

#her2_testing_market